New Combo Pill Offers Hope to Hepatitis C Patients Who Fail Other Treatment

3-drug mixture was nearly 100 percent effective in drug company trials WEDNESDAY, May 31, 2017 (HealthDay News) -- A pill that contains three powerful antiviral drugs might offer a cure for many hepatitis C patients who have failed other treatments, researchers report. The pill -- which contains the antiviral drugs sofosbuvir (Sovaldi), velpatasvir and voxilaprevir -- was nearly 100 percent effective in curing hepatitis C in patients whose disease retu...

‘No One Left Behind!’ — Update from Pacific Hepatitis C Network on Recent PharmaCare Developments

Pacific Hepatitis C Network is very happy to learn that effective March 21, an extensive list of hepatitis C treatments will be available through BC PharmaCare – at far better prices than they previously had been. The high cost of hepatitis C treatment has effectively restricted the numbers of people living with hepatitis C who could access treatment. Even with lower prices, those restrictions will remain in place until next year. Come March 2018, those r